The 2020s was the era when the full commercial promise of cell, gene and RNA therapies was to be realized - this was only accelerated by the pandemic. Collectively known as advanced therapies, they have the potential to treat numerous diseases. We now are at a pivotal moment; which will see enormous changes to usher cell, gene, and RNA therapies into the pharmacotherapeutic mainstream.

The advance therapies have had a variety of commercially successful products however the road has not been straight forward. Companies working with these therapeutics will need to innovative in both their development and marketing models. As over the next decade, each of these advanced therapies have their own potential challenges and opportunities in the ever-growing market.

Together in this webinar we will cover:

• The current status of cell, gene and RNA therapies
• What may come to pass for these advance therapies in the next decade
• The involvement of both large and emerging pharma companies and how they will need to operate in order to be commercially successful